Cargando…

Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress

Cyclins A2 and E1 regulate the cell cycle by promoting S phase entry and progression. Here, we identify a hepatocellular carcinoma (HCC) subgroup exhibiting cyclin activation through various mechanisms including hepatitis B virus (HBV) and adeno-associated virus type 2 (AAV2) insertions, enhancer hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bayard, Quentin, Meunier, Léa, Peneau, Camille, Renault, Victor, Shinde, Jayendra, Nault, Jean-Charles, Mami, Iadh, Couchy, Gabrielle, Amaddeo, Giuliana, Tubacher, Emmanuel, Bacq, Delphine, Meyer, Vincent, La Bella, Tiziana, Debaillon-Vesque, Audrey, Bioulac-Sage, Paulette, Seror, Olivier, Blanc, Jean-Frédéric, Calderaro, Julien, Deleuze, Jean-François, Imbeaud, Sandrine, Zucman-Rossi, Jessica, Letouzé, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286353/ https://www.ncbi.nlm.nih.gov/pubmed/30531861 http://dx.doi.org/10.1038/s41467-018-07552-9

Ejemplares similares

Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2017)

Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
por: Amaddeo, Giuliana, et al.
Publicado: (2015)

Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma
por: Péneau, Camille, et al.
Publicado: (2022)

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
por: Schulze, Kornelius, et al.
Publicado: (2015)

Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma
por: Poussin, Karine, et al.
Publicado: (2013)

Corrigendum: High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
por: Charles Nault, Jean, et al.
Publicado: (2013)

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
por: Nault, Jean Charles, et al.
Publicado: (2013)

aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations
por: Renault, Victor, et al.
Publicado: (2017)

Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
por: Pilati, Camilla, et al.
Publicado: (2011)

Double Heterozygous Germline HNF1A Mutations in a Patient With Liver Adenomatosis
por: Jeannot, Emmanuelle, et al.
Publicado: (2012)

Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations
por: Debaillon Vesque, Audrey, et al.
Publicado: (2020)

Genomics of Viral Hepatitis-Associated Liver Tumors
por: Péneau, Camille, et al.
Publicado: (2021)

Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors
por: Amaddeo, Giuliana, et al.
Publicado: (2012)

Hepatocellular adenoma: what is new in 2008
por: Bioulac-Sage, Paulette, et al.
Publicado: (2008)

HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines
por: Pelletier, Laura, et al.
Publicado: (2011)

Spectrum of HNF1A Somatic Mutations in Hepatocellular Adenoma Differs From That in Patients With MODY3 and Suggests Genotoxic Damage
por: Jeannot, Emmanuelle, et al.
Publicado: (2010)

Expression of fibrillin-1 in focal nodular hyperplasia of the liver: a role in microcirculation adaptability
por: Lepreux, Sébastien, et al.
Publicado: (2004)

Over-expression of glutamine synthase in focal nodular hyperplasia (part 1): Early stages in the formation support the hypothesis of a focal hyper-arterialisation with venous (portal and hepatic) and biliary damage
por: Bioulac-Sage, Paulette, et al.
Publicado: (2008)

Molecular Classification of Hepatocellular Adenomas
por: Nault, Jean Charles, et al.
Publicado: (2013)

APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures
por: Morcrette, Guillaume, et al.
Publicado: (2019)

Hypervascular nodule in a fibrotic liver overloaded with iron: identification of a premalignant area with preserved liver architecture
por: Sá Cunha, António, et al.
Publicado: (2005)

FNH-like nodules: Possible precursor lesions in patients with focal nodular hyperplasia (FNH)
por: Lepreux, Sébastien, et al.
Publicado: (2003)

Benign Hepatocellular Tumors: A Multidisciplinary Approach
por: Bioulac-Sage, Paulette, et al.
Publicado: (2013)

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNA
por: Campani, Claudia, et al.
Publicado: (2023)

Novel landscape of HLA‐G isoforms expressed in clear cell renal cell carcinoma patients
por: Tronik‐Le Roux, Diana, et al.
Publicado: (2017)

Etiology, Pathogenesis, Diagnosis, and Practical Implications of Hepatocellular Neoplasms
por: Hytiroglou, Prodromos, et al.
Publicado: (2022)

Association of adenoma and focal nodular hyperplasia: experience of a single French academic center
por: Laurent, Christophe, et al.
Publicado: (2003)

Value and Limits of Routine Histology Alone or Combined with Glutamine Synthetase Immunostaining in the Diagnosis of Hepatocellular Adenoma Subtypes on Surgical Specimens
por: Bioulac-Sage, Paulette, et al.
Publicado: (2013)

Malignant transformation of hepatocellular adenoma
por: Julien, Céline, et al.
Publicado: (2022)

Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liver
por: Villeneuve, Julien, et al.
Publicado: (2009)

Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation
por: Hocquelet, Arnaud, et al.
Publicado: (2016)

Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context
por: Bioulac-Sage, Paulette, et al.
Publicado: (2013)

Discovering cryptic splice mutations in cancers via a deep neural network framework
por: Teboul, Raphaël, et al.
Publicado: (2023)

Hepatocellular Adenomas Associated with Hepatic Granulomas: Experience in Five Cases
por: Bieze, Matthanja, et al.
Publicado: (2012)

Polyploidy spectrum: a new marker in HCC classification
por: Bou-Nader, Myriam, et al.
Publicado: (2020)

The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma
por: Ahn, Sung-Min, et al.
Publicado: (2018)

Metalloproteinase meprin α regulates migration and invasion of human hepatocarcinoma cells and is a mediator of the oncoprotein Reptin
por: Breig, Osman, et al.
Publicado: (2016)

Impact of Extended Use of Ablation Techniques in Cirrhotic Patients with Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
por: Ramtohul, Toulsie, et al.
Publicado: (2022)

Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
por: Hoshida, Yujin, et al.
Publicado: (2007)

T-cell activation discriminates subclasses of symptomatic primary humoral immunodeficiency diseases in adults
por: Picat, Marie-Quitterie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iiqj0efr0n4nck6dl31ndf5d1q